Yes, GMP (Good Manufacturing Practice) regulations are enforced by the FDA in the United States through Current Good Manufacturing Practice (cGMP) requirements. The FDA establishes and monitors GMP compliance for pharmaceuticals, medical devices, biologics, dietary supplements, and certain food products to ensure product quality, safety, and consistency.
Answer
GMP, or Good Manufacturing Practice, is a regulatory framework that governs how pharmaceutical, biotechnology, medical device, and healthcare products are manufactured and controlled. In the United States, GMP falls under the authority of the FDA, which enforces cGMP regulations through inspections, guidance documents, warning letters, and compliance actions. The term “current” in cGMP reflects the FDA’s expectation that manufacturers use up-to-date systems, technologies, and quality management practices.
FDA GMP regulations cover critical manufacturing functions including facility design, equipment qualification, personnel training, sanitation, process validation, documentation, data integrity, quality assurance, and QA/QC testing. These requirements are codified in sections of the Code of Federal Regulations (CFR), including 21 CFR Parts 210 and 211 for pharmaceutical manufacturing and 21 CFR Part 820 for medical devices. Similar GMP frameworks are also enforced internationally by organizations such as the EMA, MHRA, and WHO.
In regulated life sciences environments, GMP compliance is essential for pharmaceutical manufacturers, CDMOs, CROs, biologics facilities, and healthcare supply chain operators. FDA inspectors routinely audit manufacturing sites to verify adherence to GMP standards, review batch records, assess CAPA systems, and evaluate contamination control strategies. Noncompliance can result in warning letters, import alerts, product recalls, or production shutdowns, making GMP a foundational requirement for market authorization and patient safety.


